Increased levels of the pro-inflammatory cytokine IL-1β in the tumor microenvironment and serum have been associated with tumor growth, progression, angiogenesis, and recurrence in breast cancer (Soria et al. 2011). Here, IL1B is linked to breast carcinoma.